Table 1.
Common name | JAX stock # | Strain | Background | Gene location | Allele name | Allele type | Additional considerations | |
---|---|---|---|---|---|---|---|---|
B6 | 000664 | C57BL/6J | - | - | - | - | - | |
Trem2*R47H | 027918 | C57BL/6J- Trem2em1 Adiuj/J | C57BL/6J | Chr17:4834 6401- 48352276 | Trem2 R47H KI | Cas9 endonuclease- mediated (humanized sequence) | - Two silent mutations (lysine AAG>AAA and alanine GCC>GCA) into Trem2 - R47H mutation also introduces a cryptic splice acceptor site in exon 2, creating a novel splice variant with a deletion of 119bp at the 5’ end of exon 2. | |
APOE4 | 027894 | B6(SJL)- Apoetm1.1(APOE*4) Adiuj/J | C57BL/6J | Chr7:19696 109-19699188 | APOE4 KI | FRT site flanked PGK- neo cassette targeted mutation (gene replacement) | - Exons 2, 3, and a majority of exon 4 of the mouse Apoe gene were replaced by exons 2, 3, and 4 of the human APOE gene sequence (including a portion of the 3’ UTR sequence) - Expression of FLP recombinase was used to remove the FRT site flanked PGK-neo cassette and subsequently backcrossed to remove FLP recombinase | |
APOE4. Trem2*R47H | 028709 | B6(SJL)- Apoetm1.1(APOE*4)Adiuj Trem2em1Adiuj/J | C57BL/6J | (see above) | (see above) | (see above) | (see above) |
Mouse strains expressing Trem2*R47H and APOEε4 human late-onset Alzheimer Disease risk factors, alone or in combination, developed on the C57BL/6J background and distributed by The Jackson Laboratory (https://www.jax.org/mouse-search).